State Street Corp Centogene N.V. Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$9.02 - $12.93 $808,498 - $1.16 Million	-89,634 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.56 - $13.94 $85,282 - $112,579	8,076 Added 9.9%	89,634 $1.09 Million
Q4 2020 Feb 16, 2021	BUY	$9.44 - $13.3 $332,911 - $469,037	35,266 Added 76.18%	81,558 $879,000
Q3 2020 Nov 10, 2020	BUY	$9.3 - $25.16 $74,362 - $201,179	7,996 Added 20.88%	46,292 $438,000
Q2 2020 Aug 14, 2020	BUY	$15.99 - $22.88 $178,848 - $255,912	11,185 Added 41.26%	38,296 $876,000

Q1 2020 May 11, 2020	BUY	$9.76 - $23.8 $264,603 - $645,241	27,111 New	27,111 $542,000

2.14M

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $10.3M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.